Japanese
Title肺腺癌患者の臨床病期分類と全身骨シンチグラム
Subtitle原著
Authors小山田日吉丸*, 照井頌二*, 江口研二*, 米山武志**, 田部井敏夫***, 折井弘武****
Authors(kana)
Organization*国立がんセンター 放射線診断部, **国立がんセンター 外科, ***埼玉がんセンター 内科, ****東京都立臨床医学総合研究所
Journal核医学
Volume15
Number1
Page79-84
Year/Month1978/2
Article原著
Publisher日本核医学会
Abstract悪性腫瘍患者の骨転移巣の検索には, 99mTc-燐酸化合物による全身骨シンチグラムが大変有用であることは今やよく知られた事実である. われわれは島津製作所と協同で1972年の暮に全身スキャナを開発してそれを設置したが, その時以来99mTc-燐酸化合物を用いての肺癌症例の骨転移巣の検索がわれわれの研究課題の一つとなった. そして, すでに1975年の日本核医学会において, この方法が肺癌の臨床病期の決定に有益な情報を提供しうる可能性があることを示唆してきた. 肺癌を扁平上皮癌, 腺癌, 未分化癌の3種類に分類した場合, 後の2者は比較的早期に遠隔転移を起こし, 特に腺癌においては骨転移の頻度が高いとされている. 今回, われわれは焦点を肺腺癌症例に絞り, その臨床病期と全身骨シンチグラムの成績について検討を加えたので報告する.「症例と方法」症例は1972年の暮から1976年の9月までの間に国立がんセンターRI検査室において全身骨シンチグラムを撮った肺腺癌の症例で組織学的に確認された106例である.
Practice臨床医学:一般
Keywords
English
TitleClinical Stage Classification of Adenocarcinoma of the Lung and Whole Body Bone Scintigram
SubtitleOriginal Articles
AuthorsHiyoshimaru OYAMADA*, Shoji TERUI*, Kenji EGUCHI*, Takeshi YONEYAMA**, Toshio TABEI***, Hirotake ORII****
Authors(kana)
Organization*Department of Diagnostic Radiology, National Cancer Center, **Department of Surgery, National Cancer Center, ***Department of Internal Medicine, Saitama Cancer Center, ****Department of Radiology, Radiobiology and Nuclear Medicine, Tokyo Metropolitan Institute of Medical Science
JournalThe Japanese Journal of nuclear medicine
Volume15
Number1
Page79-84
Year/Month1978/2
ArticleOriginal article
PublisherTHE JAPANESE SOCIETY OF NUCLEAR MEDICINE
Abstract[Summary] One hundred and six patients having adenocarcinoma of the lung were studied by whole body bone scanning with 99mTc-phosphates in connection with their clinical stages. Abnormal accumulation was found in 64 patients (60.4%) , There were 64 patients who received surgical treatment. Among these 64 patients, 38 underwent bone scanning within 3 months after the establishment of their clinical stages. Twenty-two of them were classified as Stage I clinically. Pathological stage classification after the surgery revealed these 22 to be classified into 3 groups ; 6 for Pathological Stage I, 4 for Pathological Stage II and 12 for Pathological Stage III. None of these 6 in Stage I showed abnormal accumulations. However, 1 of 4 in Stage II and 6 of 12 in Stage III were found to have abnormal accumulations. Therefore, if bone scintigrams had been taken into considerations for clinical stage classification, 7 patients would have never been placed into Clinical Stage I, being expected more precise treatment. The authors recommend application of whole body bone scanning to stage classification of adenocarcinoma of the lung. Needle biopsy is also recommended to confirm the metastasis at the site of radioisotope accumulation in the rib.
PracticeClinical medicine
Keywords

【全文PDF】